Email Alert RSS
Volume 11 Issue 3
May  2020
Turn off MathJax
Article Contents
Abstract
References
Related Articles
Yang CUI, Xiao ZHANG. Comprehensive Management of Systemic Lupus Erythematosus During Pregnancy[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 270-275. DOI: 10.3969/j.issn.1674-9081.20200026
Citation: Yang CUI, Xiao ZHANG. Comprehensive Management of Systemic Lupus Erythematosus During Pregnancy[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 270-275. DOI: 10.3969/j.issn.1674-9081.20200026
shu

Comprehensive Management of Systemic Lupus Erythematosus During Pregnancy

  • Department of Rheumatology and Immunology, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou 510000, China

More Information
  • Corresponding author:

    ZHANG Xiao  Tel: 86-20-83824249, E-mail:13922255387@163.com

  • Received Date: February 04, 2020
  • Issue Publish Date: May 29, 2020
    Graphical Abstract
    • Abstract
  • Systemic lupus erythematosus(SLE) is a disease with a high incidence in women of childbearing age, especially 20-40 years old. Most patients at this age will have the need for pregnancy. However, when SLE combines with pregnancy, pregnant women are facing not only the risk of relapse and aggravation of lupus, but also the increased risk of adverse pregnancies. Therefore, it is very important to do well in the comprehensive management of pregnancy in SLE patients. This paper focused on the interaction between SLE and pregnancy, as well as the management of SLE in pregnant patients, aiming to better understand and improve the pregnancy outcome of SLE patients.
    • FullText(HTML)
    • References (40)
  • [1]
    Park MC, Park YB, Jung SY, et al. Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy[J]. Lupus, 2004,13:569-574. DOI: 10.1191/0961203304lu1063oa
    [2]
    Jakobsen IM, Helmig RB, Stengaard-Pedersen K. Maternal and foetal outcomes in pregnant systemic lupus erythematosus patients:an incident cohort from a stable referral population followed during 1990-2010[J]. Scand J Rheumatol, 2015,44:377-384. DOI: 10.3109/03009742.2015.1013982
    [3]
    Palma Dos Reis CR, Cardoso G, Carvalho C, et al. Prediction of Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus[J]. Clin Rev Allergy Immunol, 2019.doi:10.1007/s12016-019-08762-9.[Epub ahead of print].
    [4]
    Sammaritano LR. Management of Systemic Lupus Erythematosus During Pregnancy[J]. Annu Rev Med, 2017,68:271-285. DOI: 10.1146/annurev-med-042915-102658
    [5]
    Tedeschi SK, Massarotti E, Guan H, et al. Specific systemic lupus erythematosus disease manifestations in the six months prior to conception are associated with similar disease manifestations during pregnancy[J]. Lupus, 2015,24:1283-1292. DOI: 10.1177/0961203315586455
    [6]
    Kattah AG, Garovic VD. Pregnancy and Lupus Nephritis[J]. Semin Nephrol, 2015,35:487-499. DOI: 10.1016/j.semnephrol.2015.08.010
    [7]
    Cozzani E, Drosera M, Gasparini G, et al. Serology of Lupus Erythematosus:Correlation between Immunopathologi-cal Features and Clinical Aspects[J]. Autoimmune Dis, 2014,2014:321359. https://www.hindawi.com/journals/ad/2014/321359/
    [8]
    Teng YKO, Bredewold EOW, Rabelink TJ, et al. An evidence-based approach to pre-pregnancy counselling for pa-tients with systemic lupus erythematosus[J].Rheumatology, 2018,57:1707-1720. DOI: 10.1093/rheumatology/kex374
    [9]
    Brito-Zerón P, Izmirly PM, Ramos-Casals M, et al. The clinical spectrum of autoimmune congenital heart block[J]. Nat Rev Rheumatol, 2015,11:301-312. DOI: 10.1038/nrrheum.2015.29
    [10]
    Kan N, Silverman ED, Kingdom J, et al. Serial echocardiography for immune-mediated heart disease in the fetus:results of a risk-based prospective surveillance strategy[J]. Prenat Diagn, 2017,37:375-382. DOI: 10.1002/pd.5021
    [11]
    Maynard S, Guerrier G, Duffy M. Pregnancy in Women With Systemic Lupus and Lupus Nephritis[J]. Adv Chronic Kidney Dis, 2019,26:330-337. DOI: 10.1053/j.ackd.2019.08.013
    [12]
    Nahal SK, Selmi C, Gershwin ME. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus[J]. J Autoimmun, 2018,93:16-23. DOI: 10.1016/j.jaut.2018.07.016
    [13]
    Lazzaroni MG, Dall Ara F, Fredi M, et al. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus[J]. J Autoimmun, 2016,74:106-117. DOI: 10.1016/j.jaut.2016.06.016
    [14]
    Petri M. Pregnancy and Systemic Lupus Erythematosus[J]. Best Pract Res Clin Obstet Gynaecol, 2019,19:30133-30136. https://www.sciencedirect.com/science/article/pii/S1521693419301336
    [15]
    Espinosa G, Cervera R. Current treatment of antiphos-pholipid syndrome:lights and shadows[J]. Nat Rev Rheumatol, 2015,11:586-596. DOI: 10.1038/nrrheum.2015.88
    [16]
    Hwang J, Shin S, Kim Y, et al. Epidemiology of Antiphospholipid Syndrome in Korea:a Nationwide Population-based Study[J]. J Korean Med Sci, 2020,35:e35. DOI: 10.3346/jkms.2020.35.e35
    [17]
    Limper M, de Leeuw K, Lely AT, et al. Diagnosing and treating antiphospholipid syndrome:a consensus paper[J]. Neth J Med, 2019,77:98-108.
    [18]
    Lazzaroni MG, Dall Ara F, Fredi M, et al. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus[J]. J Autoimmun, 2016,74:106-117. DOI: 10.1016/j.jaut.2016.06.016
    [19]
    Cavazzana I, Andreoli L, Limper M, et al. Update on Antiphospholipid Syndrome:Ten Topics in 2017[J]. Curr Rheumatol Rep, 2018,20:15. DOI: 10.1007/s11926-018-0718-4
    [20]
    Andreoli L, Fredi M, Nalli C, et al. Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome[J]. J Autoimmun, 2012,38:J197-J208. DOI: 10.1016/j.jaut.2011.11.010
    [21]
    Ruiz-Irastorza G, Crowther M, Branch W, et al. Antiphospholipid syndrome[J]. Lancet, 2010,376:1498-1509. DOI: 10.1016/S0140-6736(10)60709-X
    [22]
    Buyon JP, Kim MY, Guerra MM, et al. Predictors of Pregnancy Outcomes in Patients With Lupus[J]. Ann Intern Med, 2015,163:153. DOI: 10.7326/M14-2235
    [23]
    Liu T, Gu J, Wan L, et al. "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort[J].Arthritis Res Ther, 2020,22:33. DOI: 10.1186/s13075-020-2131-4
    [24]
    Marchetti T, Ribi C, Perneger T, et al. Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus[J].Rheumatology, 2018,57:1350-1357. DOI: 10.1093/rheumatology/key095
    [25]
    Bertin D, Beziane A, Resseguier N, et al. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome:a 5-year retrospective study[J]. Rheumatology (Oxford), 2019, pii:z453. DOI: 10.1093/rheumatology/kez453/5599884
    [26]
    Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults[J]. Ann Rheum Dis, 2019,78:1296-1304. DOI: 10.1136/annrheumdis-2019-215213
    [27]
    中国系统性红斑狼疮研究协作组专家组, 国家风湿病数据中心. 中国系统性红斑狼疮患者围产期管理建议[J]. 中华医学杂志, 2015,95:1056-1060. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyx201514005
    [28]
    Martínez López JA, García Vivar ML, Cáliz R, et al. Recomendaciones sobre actuaciones a seguir durante la edad fértil, el embarazo, posparto y lactancia en pacientes con enfermedades reumáticas inflamatorias y autoinmunes[J]. Reumatología Clínica, 2017,13:264-281.
    [29]
    Sammaritano L, Bermas B, Chambers C, et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.[J]. Arthritis Care Res, 2020,72:461-488. DOI: 10.1002/acr.24130
    [30]
    Cyprian F, Lefkou E, Varoudi K, et al. Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond[J]. Front Immunol, 2019,10:2739. DOI: 10.3389/fimmu.2019.02739
    [31]
    Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I:standard and biologic disease modifying anti-rheumatic drugs and corticosteroids[J]. Rheumatology(Oxford), 2016,55:1693-1697. DOI: 10.1093/rheumatology/kev404
    [32]
    Marder W. Update on pregnancy complications in systemic lupus erythematosus[J]. Curr Opin Rheumatol, 2019,31:650-658. DOI: 10.1097/BOR.0000000000000651
    [33]
    Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation[J]. Ann Rheum Dis, 2016,75:795-810. DOI: 10.1136/annrheumdis-2015-208840
    [34]
    Liu X, Qiu Y, Yu ED, et al. Comparison of therapeutic interventions for recurrent pregnancy loss in association with antiphospholipid syndrome:A systematic review and network meta-analysis[J]. Am J Reprod Immunol, 2019,83:e13219. DOI: 10.1111/aji.13219
    [35]
    Sciascia S, Hunt BJ, Talavera-Garcia E, et al. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies[J].Am J Obstet Gynecol, 2016,214:271-273. https://www.ncbi.nlm.nih.gov/pubmed/26429521
    [36]
    Mekinian A, Lazzaroni MG, Kuzenko A, et al. The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome:Data from a European multicenter retrospective study[J]. Autoimmun Rev, 2015,14:498-502. DOI: 10.1016/j.autrev.2015.01.012
    [37]
    Bramham K, Thomas M, Nelson-Piercy C, et al. First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss[J]. Blood, 2011,117:6948-6951. DOI: 10.1182/blood-2011-02-339234
    [38]
    Svenungsson E, Antovic A. The Antiphospholipid Syndrome-often overlooked cause of vascular occlusions?[J]. J Intern Med, 2020,287:349-372. DOI: 10.1111/joim.13022
    [39]
    Sammaritano LR, Bermas BL. Management of pregnancy and lactation[J]. Best Pract Res Clin Rheumatol, 2018,32:750-766. DOI: 10.1016/j.berh.2019.03.007
    [40]
    Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation[J]. Ann Rheum Dis, 2016,75:795-810. DOI: 10.1136/annrheumdis-2015-208840
    • Related Articles

  • Related Articles

    [1]Society of Gynecologic Oncology, Chinese Medical Association, Branch of Colposcopy and Cervical Pathology, China Healthy Birth Science Association, Professional Committee on Cancer Prevention and Control, Chinese Preventive Medicine Association, Specialized Committee on Cervical Cancer Prevention and Control Research, China Maternal and Child Health Research Association, National Collaborative Group for Cervical Cancer Prevention and Treatment, China Cancer Foundation, Committee on Cervical Cancer, China Anti-Cancer Association, Branch of Obstetric and Gynecological Health Medicine, China International Exchange and Promotive Association for Medical and Health Care. Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 350-360. DOI: 10.12290/xhyxzz.2025-0246
    [2]LIU Shupeng, YU Mengyang, WU Xiaofei, WANG Hongyun. Clinical Landscape of Therapeutic Cancer Vaccines: Challenges and Opportunities[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1356-1363. DOI: 10.12290/xhyxzz.2024-0130
    [3]HUANG Biqing, LI Lanjuan. The Impact of Gut Microbiota on Vaccine Immune Efficacy and Potential Mechanisms[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 939-944. DOI: 10.12290/xhyxzz.2023-0173
    [4]WANG Xiaodan, ZHANG Zhan, LIU Zhaohui. Analysis of Influencing Factors for High-risk Human Papillomavirus Infection[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 153-158. DOI: 10.12290/xhyxzz.2022-0193
    [5]KONG Linghua, XIAO Xiaoping, WAN Ru, XIANG Yang. Clinical Application of ThinPrep Imaging System in Cervical Cytology[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 613-619. DOI: 10.12290/xhyxzz.2022-0221
    [6]Gynecological Oncology Society of Chinese Medical Association, Chinese Society for Colposcopy and Cervical Pathology. Chinese Expert Consensus on Clinical Application of Human Papilloma Virus Vaccine[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(2): 189-201. DOI: 10.12290/xhyxzz.2021-0082
    [7]Lan-lan JI, Zhuo-li ZHANG. How to Treat Systemic Lupus Erythematosus: Interpretation of 2019 Update of the EULAR Recommendations for the Management of Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 283-288. DOI: 10.3969/j.issn.1674-9081.20200011
    [8]Yang CUI, Xiao ZHANG. Comprehensive Management of Systemic Lupus Erythematosus During Pregnancy[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 270-275. DOI: 10.3969/j.issn.1674-9081.20200026
    [9]Bei-di CHEN, Li-dan ZHAO, Xuan ZHANG. Gut Microbiota and Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 258-263. DOI: 10.3969/j.issn.1674-9081.20200056
    [10]Yuan XIA, Xiang-pei LI. The Role of MicroRNA Regulation of Interferon-α in the Pathogenesis of Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 673-678. DOI: 10.3969/j.issn.1674-9081.2019.06.021

  • Cited by

    Periodical cited type(3)

    1. 樊阿倩，郭富蓉，秦凌花. 系统性红斑狼疮合并外阴巨大尖锐湿疣1例. 皮肤病与性病. 2024(03): 202-203 .
    2. 王小冬，蔡晓玲. 系统性红斑狼疮感染人乳头瘤病毒基因型及风险因素分析. 中国卫生检验杂志. 2023(01): 77-80 .
    3. 俞佳敏，邢燕. 系统免疫性疾病与宫颈病变. 现代妇产科进展. 2021(11): 863-865 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (504) PDF downloads (157) Cited by(3)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close